戻る
Caribou Biosciences Inc (CRBU)価格
CRBU 株価推移チャート
CRBU 財務
Caribou Biosciences Inc
$1.55
-1.89%
$-0.03
終値： Feb 17, 16:00:00 GMT-5
$1.56
0.64%
$0.01
アフターマーケット：Feb 17, 18:39:46 GMT-5
主要データ
前終値
$1.58
始値
$1.57
当日レンジ
$1.51 - $1.58
52週レンジ
$0.66 - $3.53
取引高
628.5K
平均取引高
1.0M
1株当たり利益(TTM)
-1.70
配当利回り
--
時価総額
$145.8M
CRBUとは何ですか？
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. The company is headquartered in Berkeley, California and currently employs 147 full-time employees. The company went IPO on 2021-07-23. The Company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against disease. Caribou is advancing a pipeline of off-the-shelf cell therapies from its CAR-T platform to offer broad access and rapid availability of treatments for patients with hematologic malignancies and autoimmune diseases. Its genome-editing platform, including its novel chRDNA technology, enables more precise genome editing of allogeneic cell therapies. The company is advancing its pipeline of allogeneic CAR-T cell therapies with clinical development programs targeting the treatment of hematologic malignancies and autoimmune diseases.